Modified FOLFOX-6 Plus Bevacizumab Chemotherapy for Metastatic Colorectal Cancer in Patients Receiving Hemodialysis: A Report of Three Cases and Review of the Literature

Fluorouracil plus oxaliplatin (L-OHP) (FOLFOX) plus bevacizumab (BV) therapy is commonly administered to patients with metastatic colorectal cancer. However, few reports have described L-OHP therapy in hemodialysis patients, and the efficacy and safety remain uncertain in this population. Here, we r...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Case Rep Oncol
Hlavní autoři: Funasaka, Chikako, Kanemasa, Yusuke, Shimoyama, Tatsu, Ohta, Akihito, Omuro, Yasushi
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger AG 2019
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6751430/
https://ncbi.nlm.nih.gov/pubmed/31572155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000502512
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky